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Studies on the mechanism of rubidium-induced kaliuresis. Renal
clearance and electron microprobe methods were used I) to elucidate
the effects of chronic rubidium administration on potassium transport
and 2) to localize, by the use of amiloride in acute experiments, the
tubule site of interaction between rubidium and potassium. Substitution
of drinking water by a 50 m rubidium chloride solution for 9 to 11 days
led to significant hypokalemia (plasma potassium 2.5 0.1 mM; plasma
potassium plus rubidium 3.3 0.1 mM). Compared to a control group
(reduction of plasma potassium to 3.4 0.1 m by short-term potas-
sium depletion) with a fractional potassium excretion of 2.1 0.3%,
rubidium-treated rats excreted potassium at a much higher rate of 14.6
3.0%. The potassium content of principal cells was, however,
significantly lower in rubidium-treated than in potassium-deprived
animals. Similar to experiments in which rubidium was given acutely (3
hours), chronic rubidium administration was associated with preferen-
tial accumulation of rubidium in all tubule cells relative to potassium.
Rubidium clearances were uniformly below those of potassium. Amil-
oride abolished the difference between rubidium and potassium clear-
ances and sharply reduced the excretion of both cations. In view of the
known site of action of amiloride, this suggests a distal tubule site of
rubidium action on potassium transport. Amiloride also reduced or
abolished the preferential uptake of rubidium into all but intercalated
tubule cells. Marked cell heterogeneity of rubidium accumulation into
intercalated cells was observed: One subpopulation, with low cell
chloride, retained rubidium more effectively than another subpopula-
tion with high cell chloride.
A large number of transport studies supports the view that
rubidium and potassium share many common features [1—6].
Accordingly rubidium is frequently used as a marker ion for
potassium. Studies employing renal clearance techniques [2]
and flux measurements in single tubules [3] demonstrate that
the renal excretion of rubidium and its movement across the
wall of individual nephron segments are similar to that of
potassium. However, significant differences have also been
noted [2, 7—9]. Using clearance studies and electron microprobe
analysis of single tubule cells, we showed in the rat that during
the acute administration of rubidium chloride the renal clear-
ance of rubidium is less than that of potassium, that rubidium
enhances potassium excretion, and that rubidium is concen-
trated more than potassium in all tubule cell types of the kidney
cortex [9].
The present investigation addresses two issues: First, we
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examined the effect of chronic rubidium administration on renal
potassium excretion and the concentrations of rubidium and
potassium in individual renal tubule cells. Second, we investi-
gated in clearance experiments the effects of amiloride on renal
rubidium and potassium excretion. Amiloride is known to
inhibit potassium secretion along the initial and cortical collect-
ing tubule [10—13], nephron segments which play a major role in
the regulation of renal potassium excretion. We argue that an
inhibitory effect of this diuretic on both rubidium and potassium
excretion would imply transport interaction of these cations at
the nephron sites of potassium secretion.
Methods
Dietary pretreatment of the animals
The experiments were performed on male Wistar rats main-
tained on a standard rat diet (Altromin, Lage, FRG; potassium
and sodium contents: 0.16 and 0.09 mol/kg) and tap water ad
libitum. Three groups of animals were used.
In the first group (chronic rubidium; N = 6) rubidium was
administered for 9 to 11 days by replacing the tap water with a
solution containing 50 mmol rubidium chloride per liter.
In the second group (low K; N = 6). The standard diet was
replaced for one to two days by a potassium-deficient diet (C
1037, Altromin, Lage, FRG; 3 mmol potassium per kg diet). The
rationale of this procedure was to lower the plasma potassium
concentration to levels equivalent to the sum of plasma potas-
sium plus rubidium in group 1 so that the influence of different
concentrations of potassium (plus rubidium) were minimized.
In the third group (amiloride; N = 5) standard diet and tap
water were administered until the day of study.
Preparation of animals and experimental protocol
In general the methods were similar to those used in previous
studies [9, 14—16]. Briefly, on the day of study the animals were
anesthetized by i.p. injection of mactin (Byk-Gulden, Kon-
stanz, FRG; 100 to 120 mg/kg body wt) and placed on a
thermoregulated operating table to maintain body temperature
at 37°C. The trachea, the right jugular vein, and the left femoral
artery were cannulated with polyethylene catheters. The left
kidney was approached via a flank incision, placed in a plastic
cup, freed of adherent fat and connective tissue and kept under
warm paraffin oil (38°C). The ureter was catheterized to allow
collection of urine.
In the chronic rubidium and low potassium animals clearance
studies were done at the end of the dietary treatment period.
Isotonic saline containing 30 g polyfructosan per liter was
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administered at a rate of 11 mi/hr/kg body wt. Following an
equilibration period of 60 minutes, urine was collected for 30
minutes for the measurements of flow rate, polyfructosan,
electrolytes and osmolality. Blood samples were collected at
the beginning and at the end of the clearance period.
In a separate group of chronic rubidium and low potassium
animals, only urine flow rates and urine osmolalities were
measured. Following preparation of the animals and an initial
control period of 90 minutes, an analogue of vasopressin with
specific antidiuretic effect (deamino-cys', D-arg8-vasopressin,
Sigma, Deisenhofen, FRG) was infused at a rate of 50 ng/hr/100
g body wt and urine collected for 30 minutes after 90 minutes
had elapsed. The two groups of animals were also used to
compare their fluid intake in the 24 hours preceding the exper-
iments.
In the amiloride experiments the animals received 150 mM
rubidium chloride for 180 minutes (11 mI/hr/kg body wt) after an
initial control period of 30 minutes (i.v. infusion of isotonic
saline at a rate of 11 mI/hr/kg body wt). During the last 60
minutes of this period, in addition to rubidium chloride, amilo-
ride (3 mg/hr/kg body wt) was administered intravenously. All
infusion solutions contained 30 glliter polyfructosan (mutest,
Laevosan-Gesellschaft, Linz, Austria). Blood which had been
taken at the midpoint of each 30 minute clearance period was
replaced quantitatively [9].
To assess the role of circulating levels of aldosterone on renal
potassium (rubidium) excretion in chronic rubidium and low
potassium rats, plasma aldosterone levels were measured in
seven rats kept on 50 m rubidium chloride as drinking solution
for 10 days and in six rats maintained on a potassium deficient
diet for two days.
Preparation of freeze-dried cryosections and determination of
electrolyte contents
Following the clearance measurements the renal surface was
cleansed and rinsed several times with warm (38°C) isotonic
saline. Then the kidney was removed from the animal and
shock-frozen in a 3:1 propane/isopentane mixture (—196°C).
Cryosections of about 1 sm thickness were cut in a modified
ultracryomicrotome (Ultrotome V, LKB, Broma, Sweden)
from the frozen tissue at —90°C, sandwiched between a collo-
dion and a formvar film and freeze-dried at —80°C and 10_6
ton. A detailed description of the methods has been given
previously [17]. Microprobe analysis of the freeze-dried sec-
tions was carried out in a scanning transmission electron
microscope (S 150, Cambridge Instruments, Cambridge, UK)
with an energy-dispersive X-ray detecting system (LINK Sys-
tems, High Wycombe, UK). Using an acceleration voltage of 20
kV and a probe current of 0.3 nA areas of about 1 m2 were
scanned within the nuclei of the different tubule cell types for
100 seconds. The emitted X-rays were analyzed in the energy
range between 0 and 20 keV. The rationale for restricting the
analyses to the cell nuclei as well as the criteria for distinguish-
ing between the different tubule cell types have been described
previously [15, 161. The cell element concentrations were
calculated in mmol/kg dry wt from the peak/continuum ratios
according to Hall [181.
Table 1. Plasma electrolyte concentrations, plasma osmolality and
mean body weight in rats drinking 50 m RbCl for 9 to 11 days and
in rats on a potassium deficient diet for 2 days
Chronic rubidium Short-term
administration potassium depletion
Plasma potassium 2.5 0.1 3.4 0.la
mmol/liter
Plasma rubidium 0.75 0.02
mmol/liter
Plasma potassium 3.3 0.1
plus rubidium
mmol/liter
Plasma sodium 142.2 0.6 141.9 0.5
mmol/liter
Plasma chloride 113,2 1.4 112.8 1.0
mmol/Iiter
Plasma osmolality 290 2 284 5
mOsm/kg
Mean body weight g 193 8 185 8
Number of animals 6 6
Values are means SEM.
° Significantly different from corresponding value of rubidium-treated
rats
Chemical analyses and aldosterone assay
Sodium and potassium concentrations in plasma and urine
were measured by flame photometry (IL, Lexington, Massa-
chusetts, USA). Rubidium concentrations in plasma and urine
were determined by atomic absorption spectrophotometry (Pye
Unicam, Cambridge, UK). Urine osmolality was measured by
vapor pressure osmometry (Wescor, Logan, Utah, USA) inulin
in plasma and urine by the anthrone method of FUhr, Kacz-
marczyk and KrUttgen [191. Clearance data for potassium,
rubidium, and sodium were calculated using standard formula.
Plasma aldosterone concentrations were assessed by radioim-
munoassay (Diagnostic Products Corp, Los Angeles, Califor-
nia, USA).
Presentation of data and statistical analysis
The data are presented as means SEM with (N) indicating
the number of measurements. Comparisons between two
groups of data were performed by t-test for paired or unpaired
data as appropriate. Differences with P values less than 0.05
were regarded as significant. If more than two groups had to be
compared, analysis of variance was carried out in a first step.
Differences between individual groups were then tested in a
second step by t-test using appropriately adjusted significance
levels [20].
Results
Plasma composition, plasma aldosterone levels and whole
kidney functions following chronic rubidium administration
and short-term potassium depletion
Table 1 summarizes plasma electrolyte concentrations and
plasma osmolalities in chronic rubidium and low potassium
animals. While no significant differences in plasma sodium and
chloride concentrations and in plasma osmolality were ob-
served between the two groups, the plasma potassium concen-
tration was significantly lower in the rubidium-treated group.
The sum of plasma potassium plus rubidium concentrations in
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Table 2. Renal function in rats drinking 50 mM RbCI for 9 to Ii days
and in rats on a potassium deficient diet for 2 days
Chronic
rubidium
administration
Short-term
potassium
depletion
Urine flow rate ,uJ/min/100 g 1.1 0.1 1.5 o.la
body WI
Glomerular filtration rate 0.48 0.02 0.45 0.03
ml/min/]OO g body wI
Urine potassium mmollliter 160.1 33.4 22.4 3.6a
Urinary excretion of potassium 0.174 0.039 0.032 0.003
p.mol/min/100 g body WI
Fractional potassium excretion % 14.6 3.0 2.1 Ø3
Urine rubidium mmollliter 36.4 6.7
Urinary excretion of rubidium 0.040 0.008
p.mol/min/100 g body WI
Fractional rubidium excretion %. 11.6 2.5"
Urine rubidium plus potassium 196.4 40.0
mmol/liter
Urinary excretion of rubidium plus 0.214 0.048
potassium mo1/minI1OO g body
WI
Fractional potassium plus 13.9 2.9
rubidium excretion %
Fractional sodium excretion % 0.10 0.04 0.11 0.02
Fractional chloride excretion % 0.50 0.13 0.95 o.o4
Urine osmolality mOsmlkg 2833 229 1359 l2l
Values are means SEM. In each group 6 animals were studied.
a Significantly different from corresponding value of rubidium-treated
rats
b Significantly different from fractional potassium excretion of rubid-
ium-treated animals (by paired I-test)
the chronic rubidium group (3.3 0.1 mM) was, however,
similar to the plasma potassium concentration in the low
potassium group (3.4 0.1 mM).
Plasma aldosterone levels were assessed in a separate series
of experiments. Data on plasma electrolyte concentrations in
these animals are not shown, since values identical with those
described above were obtained in both groups of animals.
Plasma aldosterone concentrations were not significantly dif-
ferent between rubidium-treated (22.5 3.1 ngldl; N = 7) and
potassium-depleted (25.4 4.4 ngldl; N = 6) animals. In both
the low potassium and chronic rubidium groups plasma aldo-
sterone levels were significantly lower than in animals main-
tained on normal rat diet (574 9.2 ng/dl; N = 6). The changes
in plasma aldosterone concentrations observed in chronic ru-
bidium rats thus cannot account for the inappropriate potassium
loss of these animals.
Table 2 provides data on renal function in chronic rubidium
and low potassium rats. Glomerular filtration rate was not
different between rubidium-treated and potassium-deprived an-
imals. Striking differences were, however, observed between
the two groups with respect to potassium excretion. Confirming
the experiments of Ornt and Tannen 21] and those of Linas et
al [221, we observed a dramatic fall in urinary potassium
excretion in the animals receiving a low potassium diet for two
days. Urinary potassium excretions, either expressed in abso-
lute or fractional terms, were markedly higher in chronic
rubidium than in low potassium rats. Whereas chronic rubidium
animals excreted an amount of potassium equivalent to 14.6%
of the filtered load, short-term potassium-depleted rats excreted
only 2.1%. We note that despite markedly higher excretion
rates of potassium, chronic rubidium animals had a lower
plasma potassium concentration (2.5 vs. 3.4 mM).
Confirming our previous results obtained in rubidium-infused
rats [9], fractional rubidium excretion in chronic rubidium
animals was slightly, but significantly lower (21%) than frac-
tional potassium excretion. Inspection of Table 2 also shows
that despite similar levels of potassium plus rubidium in chronic
rubidium animals compared to plasma potassium in low potas-
sium rats the urinary excretion of potassium plus rubidium was
almost sevenfold higher in the rubidium-treated than in the
potassium-deprived rats.
Pertinent data on urine flow rate, sodium and chloride excre-
tion and urine osmolality are also shown in Table 2. The
fractional sodium excretion was similar in both groups, but
fractional chloride excretion was modestly lower in the rubid-
ium-treated animals. Urinary osmolality was significantly lower
and urine flow rate moderately increased in potassium-deprived
rats.
In a separate group of animals, similarly pretreated with high
rubidium or low potassium regimes and receiving similar infu-
sions, fluid intake was measured and found not to be signifi-
cantly different (16.9 1.6 ml/24 hr/lOO g body wt in rubidium-
treated animals (N = 6), 14.0 0.9 ml/24 hr/100 g body wt in
potassium-depleted rats (N = 6)). Accordingly, changes in fluid
intake were not responsible for the differences in urinary
osmolalities. Furthermore, when the two groups of animals
were challenged with an analogue of vasopressin, only a very
modest increase in urine osmolality (from 1422 91 to 1519
119 mOsm/kg, P < 0.05 by paired I-test) was observed in the
potassium-depleted rats. In rubidium-treated animals, the urine
osmolality increased from an initially much higher value of 2372
243 to 2738 126 mOsm/kg (P < 0.05 by paired I-test). These
results provide additional evidence that even modest potassium
depletion compromises the urinary concentrating mechanism
[231.
Cell potassium and rubidium contents after short-term
potassium depletion and following chronic rubidium ingestion
Data on potassium and rubidium contents of individual tubule
cells in chronic rubidium and low potassium rats are listed in
Table 3. It is evident that in proximal tubule, distal convoluted
tubule, connecting tubule and principal cells rubidium replaces
and effectively substitutes for potassium such that the sum of
both cations in rubidium-treated animals is similar to the
potassium content of low potassium rats. With respect to this
latter group our data confirm the conclusions of both Orndt and
Tannen [21] and of Linas et at [22], who reported a sharp fall of
urinary potassium excretion yet no major changes in renal
tissue potassium content after one day [22] and after three days
[211. In the present study (2-day potassium depletion), the
potassium content of principal cells (626 mmoL/kg dry wt) is
only modestly, but significantly (P < 0.02) reduced compared to
a control group on normal potassium intake (670 mmollkg dry
wt [91). Potassium deprivation for longer periods (14 to 22 days)
resulted in a more pronounced fall in distal tubule cell potas-
sium content by some 20% [14].
Inspection of Table 3 also provides information on the cell ion
content of intercalated cells. Confirming previous data obtained
during short-term rubidium loading [91, two intercalated cell
Proximal tubule
cell
Distal convoluted
tubule cell
Connecting
tubule cell
Principal cell
Intercalated cell,
type I
Intercalated cell,
type II
Potassium
Rubidium
Potassium + rubidium
Potassium
Rubidium
Potassium + rubidium
Potassium
Rubidium
Potassium + rubidium
Potassium
Rubidium
Potassium + rubidium
Potassium
Rubidium
Potassium + rubidium
Potassium
Rubidium
Potassium + rubidium
Chronic rubidium
administration
333.7 8.7 (54)
223.9 4.9
557.7 11.7
432.7 12.1 (59)
176.4 4.6
609.1 14.4
452.2 10.0 (59)
170.6 4.3
622.9 12.5
485.7 11.2 (51)
178.9 6.4
664.6 15.1
443.6 18.6 (45)
168.4 5,8
612.0 19.7
172.6 11.4 (33)
376.8 14.2
547.2 15.2
Values are means SEM with the number of cells in parentheses. In each group 6 animals were studied. The potassium contents of all tubule
cell types in rubidium-treated rats are significantly different from the corresponding values in potassium-deprived animals (P <0.02)
Significantly different from sum of cell potassium plus rubidium content in rubidium-treated rats (P < 0.02)
types were distinguished on the basis of their different rubidium
content. Type I intercalated cells had a low, type II a high
rubidium content, and these differences were associated with
high and low potassium contents, respectively.
The present study also shows that the two types of interca-
lated cells can be distinguished based on their different cell
chloride contents [9]. The following data were obtained: type I
cells in chronic rubidium rats had a chloride content of 135.3
6.4 (N = 45), type II of 16.7 3.3 (N = 33) mmol/kg dry wt.
Comparable values in low potassium animals were 162.0 7.8
(N = 44) and 24.9 4.1 (N = 37) mmol/kg dry wt, respectively.
We also noted that after short-term potassium depletion the
potassium content of both types of intercalated cells (717 and
644 mmollkg dry wt) was significantly higher than the potassium
content, or the potassium plus rubidium content in control
animals [9], and in acutely [91 and chronically rubidium-loaded
rats (intercalated cell type I: 631, 649 and 612 mmol/kg dry wt;
intercalated cell type II: 583, 559 and 547 mmol/kg dry wt,
respectively). In the absence of measurements of cell dry
weight it is, however, not possible to obtain reliable estimates
of cell potassium concentrations and, accordingly, some of the
observed changes in cell ion content could be due to altered cell
volume of the intercalated cell population.
Effect of amiloride on potassium and rubidium excretion
Figure 1 depicts the effect of amiloride on renal potassium
and rubidium excretion. Several points should be noted: First,
following the start of rubidium administration the potassium
excretion increased significantly [9]. Second, it is apparent that
during the sustained rubidium administration, fractional potas-
sium excretion uniformly exceeded that of rubidium. Finally,
potassium and rubidium excretion dropped precipitously after
amiloride administration. In the last clearance period the differ-
ence in fractional excretion rates between potassium and rubid-
ium disappeared. Both the stimulating effect of rubidium on
Time. minutes
Fig. 1. Effect of amiloride on fractional excretion of potassium (0) and
rubidium (I). *significantly different from corresponding fractional
excretion rate of rubidium (by paired t-test; P < 0.05). Note the
reduction of fractional potassium and rubidium excretions after amilo-
ride. After 210 minutes excretion of both cations is less than at the
beginning of the experiments. Values are means SEM.
potassium excretion as well as the major source of rubidium in
the final urine are thus localized at those distal nephron sites
where amiloride exerts its action.
Table 4 provides a detailed summary of the effects of amilo-
ride on plasma composition and renal function. Data of the
period just prior to the infusion of amiloride are compared with
those of the last clearance period. Prior to amiloride plasma
potassium remained unchanged over a 120 minute period (mean
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Table 3. Potassium and rubidium contents (mmol/kg dry wt) of renal tubule cells in rats drinking 50 mrvi RbCl for 9 to 11 days and in rats on a
potassium deficient diet for 2 days
Short-term
potassium
depletion
587.7 8.3 (46)
611.8 8.2(57)
643.6 8.5 (51)
625.8 10.1 (52)
717.4 16.1 (44)U
643.9 10.8 (37)
100 -
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Fig. 2. Potassium (U) and rubidium (LI)
contents of different tubule cell types. Data
from rats after 3 hours ofRbCI infusion (A;
data are taken from [9); N = 6), from rats on
50 mM RbCl for 9 to II days (B; chronic
rubidium animals of this study; N = 6) and
from rats receiving RbCl and amiloride i.v.
(C; N = 5). For each cell type the sum of
rubidium plus potassium is significantly higher
in C than in either A or B (P < 0.025). The
sums of rubidium plus potassium contents of
the various cell types are not significantly
different between A and B.
Table 4. Effect of amiloride on plasma composition and renal
function in rubidium-infused rats
Rubidium infusion
Without With
amiloride amiloride
Plasma potassium 4.26 0.08 5.67 0.12"
mmol/liter
Plasma rubidium 0.70 0.03 1.12 0.05"
mmollliter
Plasma potassium plus 4.95 0.09 6.78 0.12
rubidium mmollliter
Plasma sodium mmollliter 142.4 0.8 138.2 1.1"
Urine flow rate 12.9 4.0 11.7 0.1
p/IminIIOO g body ut
Glomerular filtration rate 0.45 0.02 0.41 0.02"
mI/mm/IOU g body wt
Urine potassium 180.7 42.3 40.7 6.6"
,n,nol/liter
Fractional potassium 92.2 3.7 19.3 2.3
excretion %
Urine rubidium 19.5 3.9 7.8 1.3
mmol/liter
Fractional rubidium 63.6 3.4 18.4 1.9"
excretion %
Urine potassium plus 200.2 46.1 48.4 7.9"
rubidium mmol//iter
Fractional potassium plus 88.1 3.4 19.1 2.2"
rubidium excretion %
Urine sodium mmol//iter 90.5 10.5 301.6 6.8"
Fractional sodium 1.94 0.64 6.10 0.51
excretion %
Data are means SEM.
Data of the clearance period just prior to amiloride administration
(without amiloride) and those of the last clearance period (with amilo-
ride; Fig. 1) are compared.
" Significantly different from corresponding value obtained without
amiloride (by paired t-test)
value of 4.3 mM). Plasma rubidium increased from 0.32 to 0.70
m. As expected, plasma potassium levels were further aug-
mented after amiloride; an increase from a mean plasma potas-
sium level of 4.3 to 5.7 m was recorded over a 60 minute
period, and during the same time interval plasma rubidium rose
from 0.70 to 1.12 m. Only minor changes were observed in
plasma sodium, urine flow rate and glomerular filtration rate.
Following amiloride, there was a sharp drop in fractional
potassium excretion from 92 to 19%. Fractional rubidium
excretion, starting from a value of 64% before amiloride,
dropped to 18.4%, a value not significantly different from that of
potassium. Finally we observed a sharp increase in fractional
sodium excretion after amiloride from 1.9 to 6.1%.
Table 5 provides an overview of potassium and rubidium data
of renal tubule cells following amiloride. A graphical summary
of these data in comparison to those observed in acute 9] and
and chronic rubidium-loading is given in Figure 2. The most
striking observation is the significant increase of the sum of
potassium and rubidium content of all tubule cells following
amiloride administration.
Discussion
One of the main observations of the present study was the
sustained loss of potassium that occurred during chronic ad-
ministration of rubidium. This extends our previous observa-
tion of significant stimulation of potassium excretion by acute
administration of rubidium, a situation in which plasma potas-
sium levels were initially normal [91. In the present series of
experiments in which rubidium was administered for longer
time periods (9 to Il days), potassium continued to be excreted
at inappropriately high levels despite a significant fall in plasma
potassium concentration. Whereas mildly hypokalemic ani-
mals, deprived of potassium for only two days, were able to
sharply curtail urinary loss of potassium, animals in which
comparable plasma levels of rubidium plus potassium were
achieved by rubidium administration failed to conserve potas-
sium. Since urine flow rate was lower following chronic rubid-
ium intake than after short-term potassium depletion and uri-
nary sodium excretion similar under both conditions, these
factors cannot explain the inappropriate renal loss of potas-
sium. We conclude from these data that rubidium exerts a
powerful stimulating effect on potassium excretion.
Concerning the site of interaction between rubidium and
potassium transport, we believe that indirect factors, such as
Beck et al: Rubidium-induced kaliuresis 179
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Table 5. Potassium and rubidium contents (mmollkg dry wt) of renal tubule cells following administration of amiloride
Proximal tubule
cell
Distal convoluted
tubule cell
Connecting
tubule cell Principal cell
Intercalated cell,
type I
Intercalated cell,
type II
Potassium 483.4 10.2 (58) 538.7 10.9 (62) 608.8 13.0 (56) 617.4 13.8 (70) 562.6 14.6 (33) 307.7 16.6 (51)
Rubidium 141.8 3.8 126.5 5.0 125.3 4.2 129.0 3.0 139.9 6.7 335.2 10.8
Potassium + 625.5 12.5 665.5 13.0 735,3 14.8 746.4 15.4 702.5 14.6 642.9 12.8
rubidium
Values are means SEM with the number of cell analyses in parentheses. The data were obtained from 5 kidneys.
changes in tubule flow rate and sodium excretion do not play a
role, since they were not changed in such a way as to account
for stimulation of potassium excretion. Our experiments with
amiloride provide strong evidence that a direct cellular effect at
a distal tubule site is involved. This conclusion is based on two
lines of evidence: First, administration of amiloride sharply
reduced the fractional excretion of both cations. Second, this
diuretic also abolished the difference of urinary excretion of
rubidium and potassium that was typically observed. Accepting
a distal site of rubidium and potassium secretion, the equal
excretion rates of the two cations during amiloride administra-
tion suggest that both cations are similarly and extensively
reabsorbed by the proximal tubule and the loop of Henle.
Principal cells of the initial and cortical collecting tubule have
been identified as the main site of potassium secretion [13,
24—28]. It is therefore of interest to consider rubidium and
potassium levels in these cells under conditions of chronic
rubidium loading. Similar to results in acute rubidium-loading
experiments [9], we noted a sharp fall in potassium content at a
time when potassium secretion was stimulated and plasma
potassium levels had significantly declined. It is most reason-
able to assume that the low potassium content after rubidium
treatment reflects a proportionate fall in cell potassium
concentration.' Accordingly enhanced secretion of potassium
ions across the apical cell membrane cannot be mediated by an
increase in the chemical driving force, because cell potassium
declined and luminal potassium may safely be assumed to have
increased in view of the high urinary potassium concentrations
(160 mM) that accompanied the sustained kaliuresis. Hence, we
are left with the possibilities of a specific effect of rubidium on
either the apical potassium permeability or the apical electrical
potential difference as the cause of stimulation of potassium
secretion. Support for the hypothesis that these factors are
important is the fact that cell potassium is partially replaced by
rubidium, a cation that is less permeant than potassium [9, 30,
31]. Replacement of potassium by rubidium would depolarize
the apical cell membrane, a factor known to stimulate potas-
sium secretion [13, 32]. Potassium substitution can be expected
to have a larger effect on the apical than basolateral potassium
An estimate of principal cell potassium concentration can be
obtained by comparing the mean value of the net potassium counts of all
principal cells in chronic rubidium and low potassium rats with the
mean net potassium counts determined in a large number of cryosec-
tions from a standard with known potassium concentration which had
been cut separately from the renal tissue. If the conditions of sectioning
are identical for standard and tissue the mean section thickness of
standard and tissue should also be identical [29]. Using this approach,
potassium concentrations of 88 and 122 mmol/kg wet wt are obtained in
principal cells for chronic rubidium and low potassium rats, respec-
tively.
efflux, because the intrinsic potassium permeability of the
apical membrane exceeds that of the basolateral by a factor of
4 to 6 [33, 34].
It is of interest that Palmer and Frindt [35], in the apical
membrane of the rat collecting tubule, and White et a! [361, in a
distal tubule cell culture largely made up of principal cells, have
observed a small conductance potassium channel with a high
open probability that permits passage of both potassium and
rubidium ions. It is possible that this channel plays a role in
rubidium transport and the stimulation of potassium secretion
by cytoplasmic rubidium. The significance of another potassium
channel, discovered in the apical membrane of the rabbit and
rat cortical collecting tubule [31], in the rubidium-potassium
interaction is unknown.
Our previous studies had indicated considerable accumula-
tion of rubidium in all tubule cells [9]. We confirm these results
in the present study. Figure 2 summarizes the potassium and
rubidium contents of tubule cells following acute and chronic
rubidium administration. Results obtained in acute experiments
after amiloride are included for comparison, With exception of
intercalated type II cells in which the rubidium content was
almost twice that found in acute experiments, the rubidium
content of all cells was slightly higher in chronic than in acute
rubidium experiments. The higher cell rubidium content may
have been caused by the higher plasma rubidium/potassium
ratio since both cations are transported actively into tubule cells
via the Na-K-ATPase.
The effects of amiloride on the distribution of potassium and
rubidium in acutely rubidium-treated animals are also summa-
rized in Figure 2. As pointed out before, the sum of potassium
and rubidium is higher in all cell types following amiloride
administration. This is due largely to the selective increase in
potassium content of proximal, distal convoluted tubule, con-
necting tubule, and principal cells. Assuming that the cell
volume was not altered by amiloride, this increase in cell
potassium plus rubidium content is equivalent to a rise in cell
potassium plus rubidium concentration by about 15 mmol/kg
wet wt.2 It is possible, but not certain that some of the following
factors may be responsible for the increased cell potassium
levels. In distal tubule cells with a significant apical sodium
permeability, activity measurements in single Amphiuma col-
lecting tubule cells have shown a fall of sodium of some 10
mmol/liter and a similar rise in potassium activity [37]. Thus
replacement of sodium by potassium may contribute to the
increase in cell potassium observed in the present experiments.
2 This calculation is based on a mean cell dry weight of all tubule cells
of 20g% [15] and on the assumption that cell volume was not affected by
amiloride.
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Fig. 3. Relation of cell to plasma ratios of
rubidium to those of potassium in dfferent
tubule cell types. Data (means SEM) were
obtained in rats after 3 hours of RbCI infusion
(black bars; data are from [9]; N = 6), in rats
on 50 mM RbCI for 9 to 11 days (open bars;
chronic rubidium animals of this study; N =
6) and in rats receiving RbCI and amiloride
iv. (hatched bars, amiloride group of this
study; N = 5). Values above unity indicate
preferential cell rubidium accumulation
relative to potassium. *significantly different
from data obtained after 3 hours of RbCI
infusion, P < 0.025; significantly different
from data observed in rats on 50 msi RbCI for
9 toll days, P <0.025.
This mechanism, however, cannot play a major role in those
tubule cells in which amiloride-sensitive sodium channels do
not constitute a major pathway of sodium entry. A second
factor that may affect potassium uptake in all tubule cells is the
pronounced increase in plasma potassium and rubidium con-
centrations during amiloride administration (Table 4), because
elevated plasma potassium levels are paralleled by increased
cell potassium concentrations [9, 151.
The present studies again demonstrate that rubidium is avidly
taken up by all tubule cells [7, 9, 38]. Such displacement of
potassium by rubidium has been shown to lead to significant
depletion of potassium also in muscle cells [39]. This results in
cell/plasma concentration ratios of rubidium to exceed those of
potassium in conditions of acute and chronic rubidium loading,
indicating preferential intracellular rubidium accumulation un-
der these conditions. Figure 3 summarizes these results and
also includes data of rubidium/potassium accumulation ratios in
amiloride-treated animals. Two points should be noted. First,
acute and chronic rubidium loading led to similar accumulation
of rubidium in all tubule cells. One notable exception were
intercalated cells of type II. In these significantly higher accu-
mulation ratios were noted after the longer period of rubidium
administration. Whereas steady state conditions are obtained in
most tubule cells already after three hours, the kinetics of
rubidium uptake and exit in intercalated type II cells are
apparently much slower. This is apparent from the observation
that, in contrast to all other cell types, chronic rubidium
pretreatment led to a more extensive replacement of potassium.
We have pointed out previously that one possibility to
explain preferential rubidium accumulation in tubule cells may
be a lower passive rubidium efflux compared to that of potas-
sium [9]. The alternative explanation of active uptake of rubid-
ium exceeding that of potassium is unlikely, because selectivity
of rubidium over potassium of the Na-K pump has not been
observed [40]. The interpretation of lower rubidium than potas-
sium permeability is consistent with experimental observations
showing that single potassium channels discriminate between
the two cations [30, 31, 41, 42]. Intercalated cells, although
having fewer K channels in view of their low pump activity [16,
43], may contain perhaps an abundance of channels with low
rubidium conductance. Inspection of Figure 3 shows that amil-
oride either diminishes or even abolishes the difference between
rubidium and potassium accumulation in proximal tubule, distal
convoluted tubule, connecting tubule and principal cells. This
effect was absent in intercalated cells. Since amiloride impairs
preferential rubidium accumulation in tubule cells that lack
apical sodium channels, it is possible that diminished basolat-
eral Na-H exchange may mediate the amiloride effect [44]. The
precise mechanism of this action is not known, but may include
alterations in cell pH. These may involve modulation of cation
channel kinetics with loss of discrimination between potassium
and rubidium. A direct inhibitory effect of amiloride upon
basolateral Na-K pump activity and a secondary blocking effect
on potassium conductance [37] is unlikely, because net trans-
port of sodium is only inhibited in distal tubule cells having a
significant apical amiloride-blockable sodium conductance.
Conclusions
Chronic rubidium loading induces hypokalemia and sustained
loss of potassium, Enhanced potassium excretion is indepen-
dent of changes in plasma potassium and occurs despite a
diminished potassium content of principal cells. Similar to acute
rubidium loading chronic administration also leads to preferen-
tial cell rubidium retention, particularly in one subpopulation of
intercalated cells. Amiloride sharply lowers the excretion of
both potassium and rubidium and abolishes the difference of
excretion of the two cations. These observations suggest a
distal tubule site of rubidium secretion and of interaction
between rubidium and potassium.
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